BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19134254)

  • 1. [Clinical and pathological study of 47 cases with Alport syndrome].
    He X; Liu GL; Xia ZK; Ren XG; Gao YF; Fan ZM; Fu YF; Fu J; Gao CL; Mao S; Chen R
    Zhonghua Er Ke Za Zhi; 2008 Dec; 46(12):914-8. PubMed ID: 19134254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and pathological features of Alport syndrome in children].
    Zhu CH; Huang SM; Wu HM; Bao HY; Chen Y; Han Y; Zhao F; Zhang AH; Zhang WZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Mar; 12(3):188-91. PubMed ID: 20350427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
    Chen N; Pan X; Ren H; Dong D
    Chin Med J (Engl); 1998 Sep; 111(9):797-802. PubMed ID: 11155669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
    Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
    Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thin basement membrane nephropathy.
    Savige J; Rana K; Tonna S; Buzza M; Dagher H; Wang YY
    Kidney Int; 2003 Oct; 64(4):1169-78. PubMed ID: 12969134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of family studies and kidney biopsies in children with renal hematuria].
    Pistor K; Bachmann H; Rumpelt HJ; Olbing H
    Monatsschr Kinderheilkd; 1985 May; 133(5):269-73. PubMed ID: 4010678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal basement membrane alpha 5(IV) expression in females with Alport syndrome and severity of renal disease.
    Massella L; Onetti Muda A; Faraggiana T; Bette C; Renieri A; Rizzoni G
    Kidney Int; 2003 Nov; 64(5):1787-91. PubMed ID: 14531812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of clinical features and type IV collagen alpha-chain distribution in Chinese patients with Alport syndrome.
    Wei G; Zhihong L; Huiping C; Caihong Z; Zhaohong C; Leishi L
    Nephrol Dial Transplant; 2006 Nov; 21(11):3146-54. PubMed ID: 16940319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and pathological features and the misdiagnosis of childhood Alport syndrome: a retrospective analysis of 91 cases].
    Chen YZ; Sun LZ; Wang HY; Jiang XY; Mo Y; Yue ZH; Chen HM; Liu T; Lin HR
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Apr; 19(4):371-375. PubMed ID: 28407818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.
    Buzza M; Wang YY; Dagher H; Babon JJ; Cotton RG; Powell H; Dowling J; Savige J
    Kidney Int; 2001 Aug; 60(2):480-3. PubMed ID: 11473630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Features of clinical phenotype and genotype in Alport syndrome: a monocentric study].
    Sun L; Kuang X; Hao S; Wang P; Niu X; Zhu G; Zhou J; Huang W
    Zhonghua Er Ke Za Zhi; 2015 Feb; 53(2):114-8. PubMed ID: 25876686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology, ultrastructure, and clinical phenotypes in thin glomerular basement membrane disease variants.
    Liapis H; Gökden N; Hmiel P; Miner JH
    Hum Pathol; 2002 Aug; 33(8):836-45. PubMed ID: 12203217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A child with genetic FN1 mutation in the absence of classic glomerulopathy with fibronectin deposits(GFND) findings on biopsy.
    Yang XQ; Shen T
    BMC Nephrol; 2022 Jul; 23(1):250. PubMed ID: 35836154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis.
    Haas M
    Arch Pathol Lab Med; 2009 Feb; 133(2):224-32. PubMed ID: 19195966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of diagnosis and treatment of Alport syndrome].
    An XG; Zhang YQ; Ding J; Wang F; Xiao HJ; Yao Y
    Zhonghua Er Ke Za Zhi; 2016 Sep; 54(9):669-73. PubMed ID: 27596081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and pathological characteristics of children with dense deposit disease].
    Liu JC; Yang JY; Xiao HJ; Huang JP; Yao Y; Li X; Wang SX
    Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):593-7. PubMed ID: 19951492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathological features and clinical manifestations in 313 children with nephropathy under 6].
    Dang XQ; Cao Y; Yi ZW; Xu ZC; He XJ; Huang DL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):227-32. PubMed ID: 18382057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of the multi-pronged approach in the diagnosis of Alport syndrome for 22 children in Northeast China.
    Zhang L; Sun BC; Zhao BG; Ma QS
    BMC Nephrol; 2020 Jul; 21(1):294. PubMed ID: 32703181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carriers of Autosomal Recessive Alport Syndrome with Thin Basement Membrane Nephropathy Presenting as Focal Segmental Glomerulosclerosis in Later Life.
    Deltas C; Savva I; Voskarides K; Papazachariou L; Pierides A
    Nephron; 2015; 130(4):271-80. PubMed ID: 26201269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.